Technical Analysis for CYTH - Cyclo Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 0.72 | -3.53% | -0.03 |
CYTH closed down 3.53 percent on Friday, November 1, 2024, on 43 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 7
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 50 DMA | Bearish | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Doji - Bullish? | Reversal | 0.00% | |
| Stochastic Reached Oversold | Weakness | 0.00% | |
| BB Squeeze + Lower Band Touch | Range Contraction | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Bullish Engulfing | Bullish | -3.53% | |
| Crossed Above 50 DMA | Bullish | -3.53% |
| Alert | Time |
|---|---|
| 50 DMA Support | about 21 hours ago |
| Non-ADX 1,2,3,4 Pullback Entry | about 21 hours ago |
| Rose Above Previous Day's High | about 21 hours ago |
| Down 5% | about 21 hours ago |
| Down 3% | about 21 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/07/2024
Cyclo Therapeutics, Inc. is a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C and Alzheimer’s Disease. The company’s Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is the subject of three ongoing formal clinical trials for Niemann-Pick Disease Type C, a rare and fatal genetic disease. The company is planning an early phase clinical trial using Trappsol Cyclo intravenously in Alzheimer’s Disease based on encouraging data from an Expanded Access program for late-onset Alzheimer’s Disease. Additional indications for the active ingredient in Trappsol Cyclo are in development.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Clinical Medicine Rare Diseases Alzheimer's Disease Lipid Storage Disorders
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Clinical Medicine Rare Diseases Alzheimer's Disease Lipid Storage Disorders
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 2.115 |
| 52 Week Low | 0.5946 |
| Average Volume | 45,892 |
| 200-Day Moving Average | 1.23 |
| 50-Day Moving Average | 0.73 |
| 20-Day Moving Average | 0.76 |
| 10-Day Moving Average | 0.75 |
| Average True Range | 0.05 |
| RSI (14) | 45.05 |
| ADX | 15.02 |
| +DI | 11.03 |
| -DI | 16.32 |
| Chandelier Exit (Long, 3 ATRs) | 0.67 |
| Chandelier Exit (Short, 3 ATRs) | 0.82 |
| Upper Bollinger Bands | 0.80 |
| Lower Bollinger Band | 0.71 |
| Percent B (%b) | 0.12 |
| BandWidth | 12.26 |
| MACD Line | -0.01 |
| MACD Signal Line | -0.01 |
| MACD Histogram | -0.0025 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.78 | ||||
| Resistance 3 (R3) | 0.78 | 0.77 | 0.77 | ||
| Resistance 2 (R2) | 0.77 | 0.75 | 0.77 | 0.77 | |
| Resistance 1 (R1) | 0.74 | 0.74 | 0.76 | 0.74 | 0.76 |
| Pivot Point | 0.73 | 0.73 | 0.73 | 0.73 | 0.73 |
| Support 1 (S1) | 0.70 | 0.71 | 0.72 | 0.70 | 0.68 |
| Support 2 (S2) | 0.69 | 0.70 | 0.69 | 0.67 | |
| Support 3 (S3) | 0.66 | 0.69 | 0.67 | ||
| Support 4 (S4) | 0.66 |
